Shareholding disclosure

Glaxo Group Limited

Declared position

4.353%

Threshold

Crossed upwards

Timeline

Published

08.08.2025

Transaction

06.08.2025

Voting rights breakdown

Voting rights acquired4.353%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000QM07

Beneficial owner

Glaxo Group Limited

Declared address

Glaxo Group Limited, London, GB

Expiry of IPO lock-up restriction

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Glaxo Group Limited

BioVersys AG08.08.2025ZA01-000000000QM07

Disclosure summary

Glaxo Group Limited disclosed a holding in BioVersys AG on the acquisition side, published by SIX Exchange Regulation on 08.08.2025, at 4.353% of voting rights. Notice category: Single shareholder.

Disclosed position

4.353%

Voting rights acquired

Voting rights acquired4.353%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Glaxo Group Limited disclosed a holding in BioVersys AG, published on 08.08.2025.

Publication date08.08.2025

Transaction date06.08.2025

Issuing companyBioVersys AG

Beneficial ownerGlaxo Group Limited

Declared addressGlaxo Group Limited, London, GB

CategorySingle shareholder

Voting rights acquired4.353%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000QM07

Conditions

Expiry of IPO lock-up restriction

Source: SIX Exchange Regulation · Publication date: 08.08.2025

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open